Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]

Susana M. Campos; William E. Brady; Katherine M. Moxley; Roisin E. O'Cearbhaill; Paula S. Lee; Paul A. DiSilvestro; Jacob Rotmensch; Peter G. Rose; Premal H. Thaker; David M. O'Malley; Parviz Hanjani; Rosemary E. Zuna; Martee L. Hensley

doi:10.1016/j.ygyno.2014.08.011

Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]

Susana M. Campos, William E. Brady, Katherine M. Moxley, Roisin E. O'Cearbhaill, Paula S. Lee, Paul A. DiSilvestro, Jacob Rotmensch, Peter G. Rose, Premal H. Thaker, David M. O'Malley, Parviz Hanjani, Rosemary E. Zuna, Martee L. Hensley

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	624
Number of pages	1
Journal	Gynecologic oncology
Volume	135
Issue number	3
DOIs	https://doi.org/10.1016/j.ygyno.2014.08.011
State	Published - Dec 1 2014

Access to Document

10.1016/j.ygyno.2014.08.011

Cite this

Campos, S. M., Brady, W. E., Moxley, K. M., O'Cearbhaill, R. E., Lee, P. S., DiSilvestro, P. A., Rotmensch, J., Rose, P. G., Thaker, P. H., O'Malley, D. M., Hanjani, P., Zuna, R. E., & Hensley, M. L. (2014). Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]. Gynecologic oncology, 135(3), 624. https://doi.org/10.1016/j.ygyno.2014.08.011

@article{a269be881ff54e41bfd1719f3d200348,

title = "Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]",

author = "Campos, {Susana M.} and Brady, {William E.} and Moxley, {Katherine M.} and O'Cearbhaill, {Roisin E.} and Lee, {Paula S.} and DiSilvestro, {Paul A.} and Jacob Rotmensch and Rose, {Peter G.} and Thaker, {Premal H.} and O'Malley, {David M.} and Parviz Hanjani and Zuna, {Rosemary E.} and Hensley, {Martee L.}",

year = "2014",

month = dec,

day = "1",

doi = "10.1016/j.ygyno.2014.08.011",

language = "English",

volume = "135",

pages = "624",

journal = "Gynecologic oncology",

issn = "0090-8258",

number = "3",

}

Campos, SM, Brady, WE, Moxley, KM, O'Cearbhaill, RE, Lee, PS, DiSilvestro, PA, Rotmensch, J, Rose, PG, Thaker, PH, O'Malley, DM, Hanjani, P, Zuna, RE & Hensley, ML 2014, 'Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]', Gynecologic oncology, vol. 135, no. 3, pp. 624. https://doi.org/10.1016/j.ygyno.2014.08.011

Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]. / Campos, Susana M.; Brady, William E.; Moxley, Katherine M. et al.
In: Gynecologic oncology, Vol. 135, No. 3, 01.12.2014, p. 624.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to

T2 - A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]

AU - Campos, Susana M.

AU - Brady, William E.

AU - Moxley, Katherine M.

AU - O'Cearbhaill, Roisin E.

AU - Lee, Paula S.

AU - DiSilvestro, Paul A.

AU - Rotmensch, Jacob

AU - Rose, Peter G.

AU - Thaker, Premal H.

AU - O'Malley, David M.

AU - Hanjani, Parviz

AU - Zuna, Rosemary E.

AU - Hensley, Martee L.

PY - 2014/12/1

Y1 - 2014/12/1

UR - http://www.scopus.com/inward/record.url?scp=84920723634&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2014.08.011

DO - 10.1016/j.ygyno.2014.08.011

M3 - Comment/debate

AN - SCOPUS:84920723634

SN - 0090-8258

VL - 135

SP - 624

JO - Gynecologic oncology

JF - Gynecologic oncology

IS - 3

ER -

Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]

Access to Document

Other files and links

Cite this